The urologist's view of male overactive bladder: Discrepancy between reality and belief in practical setting

Yonsei Medical Journal

Volumn 51, Issue 3, 2010, Pages 432-437

  Lee, Seung Hwan ^a   Kim, Joon Chul ^b   Lee, Kyu Sung ^c   Lee, Jeong Gu ^d   Park, Choal Hee ^e   Hong, Sung Joon ^a   Kim, Choung Soo ^f   Park, Jong Kwan ^g   Chung, Byung Ha ^a  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Keimyung University School of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Chonbuk National University Medical School   (South Korea)

Author keywords

Anticholinergics; Benign prostatic hyperplasia; Bladder outlet obstruction; Overactive bladder; Physician's practice patterns

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADVERSE OUTCOME; ARTICLE; AWARENESS; CLINICAL PRACTICE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LOWER URINARY TRACT SYMPTOM; MONOTHERAPY; NOCTURIA; OVERACTIVE BLADDER; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PROSTATE HYPERTROPHY; REGISTER; STRUCTURED QUESTIONNAIRE; URINE RETENTION; UROLOGY; XEROSTOMIA;

ADRENERGIC ALPHA-ANTAGONISTS; CHOLINERGIC ANTAGONISTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE; URINARY RETENTION; UROLOGY;

EID: 77954248306     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.3.432     Document Type: Article

References (18)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21: 167-78.
2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-14.
3. Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006;49:651-8.
4. Abdel-Aziz KF, Lemack GE. Overactive bladder in the male patient: bladder, outlet, or both? Curr Urol Rep 2002;3:445-51.
5. de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol 2003;169:535-9.
6. Goepel M, Hoffmann JA, Piro M, Rübben H, Michel MC. Prevalence and physician awareness of symptoms of urinary bladder dysfunction. Eur Urol 2002;41:234-9.
7. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001;87:760-6.
8. Djavan B, Nickel JC, de la Rosette J, Abrams P. The urologist view of BPH progression: results of an international survey. Eur Urol 2002;41:490-6.
9. Moorthy P, Lapitan MC, Quek PL, Lim PH. Prevalence of overactive bladder in Asian men: an epidemiological survey. BJU Int 2004;93:528-31.
10. Knutson T, Edlund C, Fall M, Dahlstrand C. BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma. Neurourol Urodyn 2001;20:237-47.
11. Ameda K, Sullivan MP, Bae RJ, Yalla SV. Urodynamic characterization of nonobstructive voiding dysfunction in symptomatic elderly men. J Urol 1999;162:142-6.
12. Johansson C, Hellström L, Ekelund P, Milsom I. Urinary incontinence: a minor risk factor for hip fractures in elderly women. Maturitas 1996;25:21-8.
13. Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001;166:563-8.
14. Choo MS, Ku JH, Park CH, Lee YS, Lee KS, Lee JG, et al. Prevalence of nocturia in a Korean population aged 40 to 89 years. Neurourol Urodyn 2008;27:60-4.
15. Abrams P, Kaplan S, De Koning Gans HJ, Millard R. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006;175:999-1004.
16. Kaplan SA,Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 2005;174:2273-5.
17. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993;150:351-8.
18. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf) 2005;27: 281-91.